Use of Severity Scoring and Stratification Factors in Clinical Trials of Hospital-Acquired and Ventilator-Associated Pneumonia
Open Access
- 31 July 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 51 (S1), S67-S80
- https://doi.org/10.1086/653052
Abstract
Clinical studies of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) enroll patients with a very wide spectrum of disease, in part, related to the patient and/or host, the causative pathogen, and the severity of the pulmonary disease, severity of illness, and other comorbidities. Studies have identified the presence of some baseline variables (eg, Acute Physiologic Assessment and Chronic Health Evaluation II score <= 20 or absence of comorbidities) as independent predictors of survival. Incorporation of severity scoring and risk adjustment in clinical trials of HAP and VAP may be a significant advancement because it has been noted that all-cause mortality varies widely on the basis of a number of these factors. In this article, we review the use of severity scoring and risk stratification factors, including time of onset, severity of disease, scoring systems, underlying disease and comorbidities, and effects of prior antibiotic therapy (including impact on treatment effect) in clinical trials of HAP and/or VAP.This publication has 48 references indexed in Scilit:
- Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsisCritical Care Medicine, 2009
- Better conduct of clinical trials: The control group in critical care trialsCritical Care Medicine, 2009
- Improving clinical trials in the critically ill: Unique challenge—SepsisCritical Care Medicine, 2009
- Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shockIntensive Care Medicine, 2008
- Severity scoring in the ICU: a reviewActa Anaesthesiologica Scandinavica, 2008
- Differences in Early- and Late-Onset Ventilator-Associated Pneumonia Between Surgical and Trauma Patients in a Combined Surgical or Trauma Intensive Care UnitThe Journal of Trauma and Acute Care Surgery, 2008
- Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumoniaCritical Care, 2008
- Diagnosis of ventilator-associated pneumonia: a systematic review of the literatureCritical Care, 2008
- Efficacy and Safety of Epoetin Alfa in Critically Ill PatientsThe New England Journal of Medicine, 2007
- Treatment Failure in Patients with Ventilator-Associated PneumoniaSeminars in Respiratory and Critical Care Medicine, 2006